Markets
MNK

KaloBios (KBIO) Worth Watching: Stock Jumps 12.7% - Tale of the Tape

An image of stock prices rising and declining in value
Credit: Shutterstock photo

KaloBios Pharmaceuticals, Inc. ( KBIO ) was a big mover last session, as the company saw its shares rise nearly 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the past one month's volatile price range of $1.70 to $2.00.

This biopharmaceutical company has seen 2 positive estimate revisions in the last 60 days. The Zacks Consensus Estimate has also moved higher over the same time frame. This implies solid trading ahead for KaloBios. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.

KaloBios currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Some other Medical Drug stocks worth considering are Akorn, Inc. ( AKRX ), Mallinckrodt plc ( MNK ) and Ariad Pharmaceuticals Inc. ( ARIA ). While Akorn and Mallinckrodt sport a Zacks Rank #1 (Strong Buy), Ariad carries the same Zacks Rank as KaloBios.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Day s. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

KALOBIOS PHARMA (KBIO): Free Stock Analysis Report

AKORN INC (AKRX): Free Stock Analysis Report

MALLINCKRODT PL (MNK): Free Stock Analysis Report

ARIAD PHARMA (ARIA): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MNK

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More